# US 2018/0024108 A1 · Systems and methods for screening a sample based on multiple reaction monitoring mass spectrometry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0024108 A1
- Document ID: US20180024108A1
- Status: Published application
- Kind: A1
- Application number: 15/649,763
- Filed: 2017-07-14
- Published: 2018-01-25
- Earliest claimed: 2016-07-22
- Assignees: Purdue Research Foundation
- Applicants: Purdue Research Foundation
- Inventors: Robert Graham Cooks; Christina Ramires Ferreira; Tiago Sobreira
- Web page: https://patentgrep.com/patent/US20180024108A1

## CPC

- G01N 33/487: of liquid biological material
- G06F 16/283: {Multi-dimensional databases or data warehouses, e.g. MOLAP or ROLAP}
- G16C 20/00: Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- H01J 49/0036: {Step by step routines describing the handling of the data generated during a measurement}
- H01J 49/004: {Combinations of spectrometers, tandem spectrometers, e.g. MS/MS, MSn}
- H01J 49/005: {by collision with gas, e.g. by introducing gas or by accelerating ions with an electric field}
- H01J 49/165: {Electrospray ionisation}
- H01J 49/424: {Three-dimensional ion traps, i.e. comprising end-cap and ring electrodes}
- H04L 1/0072: {Error control for data other than payload data, e.g. control data}
- G01N 2560/00: Chemical aspects of mass spectrometric analysis of biological material
- G01N 2570/00: Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
- G01N 2800/2835: Movement disorders, e.g. Parkinson, Huntington, Tourette
- G16H 50/70: for mining of medical data, e.g. analysing previous cases of other patients
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- H01J: ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS (spark-gaps H01T; electric arc lamps H05B31/00; particle accelerators H05H)
- H04L: TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION (arrangements common to telegraphic and telephonic communication H04M)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

The invention generally relates to systems methods for screening a sample based on multiple reaction monitoring mass spectrometry. In certain embodiments, the invention provides methods for screening a sample that involve ionizing a sample. Mass spectrometry is then used in order to monitor specific transitions connecting one or more ion pairs within the sample in order to generate a multidimensional chemical profile of the sample. Then, the multidimensional chemical profile of the sample is compared to a database of reference multidimensional chemical profiles, thereby screening the sample. Each reference multidimensional chemical profile is produced from a training set of data.

## Claims

### Claim 1

A method for screening a sample, the method comprising:
ionizing a sample;
monitoring by mass spectrometry specific transitions connecting one or more ion pairs within the sample in order to generate a multidimensional chemical profile of the sample; and
comparing the multidimensional chemical profile of the sample to a database of reference multidimensional chemical profiles, wherein each reference multidimensional chemical profile is produced from a training set of data, thereby screening the sample.

### Claim 2 (depends on 1)

The method according to claim 1, wherein ionizing is by an ambient ionization technique.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the ambient ionization technique is paper spray ionization or electrosonic spray ionization.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the sample is a biological sample, and the training set of data is from a population of patients with a known disease status.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the biological sample is a human tissue or body fluid sample.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the human tissue or body fluid sample is a cerebrospinal fluid sample.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the cerebrospinal fluid sample is screened for Parkinson's disease.

### Claim 8 (depends on 7)

The method according to claim 7, wherein the multidimensional chemical profile of the sample comprises a sum of an abundance of each of the ion pairs selected from the group consisting of: 134.1→72.4; 177→141.1; 76.2→59.4; and 184→125.2, divided by an abundance of the ion pair 188→171.

### Claim 9 (depends on 7)

The method according to claim 7, wherein the multidimensional chemical profile of the sample comprises an abundance of the ion pair 188→171.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the ion pair 188→171 represents N8- or N1-acetylspermidine.

### Claim 11

A method for screening a sample, the method comprising:
receiving, to a computer, mass spectrometry data on a sample obtained by multiple reaction monitoring, wherein the mass spectrometry data comprises specific transitions connecting one or more ion pairs within the sample;
applying, via the computer, an unsupervised multivariate analysis to the mass spectrometry data in order to generate a multidimensional chemical profile of the sample; and
comparing, via the computer, the multidimensional chemical profile of the sample to a database of reference multidimensional chemical profiles, wherein each reference multidimensional chemical profile is produced from a training set of data, thereby screening the sample.

### Claim 12 (depends on 11)

The method according to claim 11, wherein prior to the receiving step, the method further comprises:
ionizing the sample to produce an ionized sample; and
analyzing the ionized sample using multiple reaction monitoring mass spectrometry.

### Claim 13 (depends on 12)

The method according to claim 12, wherein ionizing is by an ambient ionization technique.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the ambient ionization technique is paper spray ionization or electrosonic spray ionization.

### Claim 15 (depends on 11)

The method according to claim 11, wherein the sample is a biological sample, and the training set of data is from a population of patients with a known disease status.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the biological sample is a human tissue or body fluid sample.

### Claim 17 (depends on 16)

The method according to claim 16, wherein the human tissue or body fluid sample is a cerebrospinal fluid sample.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the cerebrospinal fluid sample is screened for Parkinson's disease.

### Claim 19 (depends on 18)

The method according to claim 18, wherein the multidimensional chemical profile of the sample comprises a sum of an abundance of each of the ion pairs selected from the group consisting of: 134.1→72.4; 177→141.1; 76.2→59.4; and 184→125.2, divided by an abundance of the ion pair 188→171.

### Claim 20 (depends on 18)

The method according to claim 18, wherein the multidimensional chemical profile of the sample comprises an abundance of the ion pair 188→171.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the ion pair 188→171 represents N8- or N1-acetylspermidine.
